Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 5/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5691082 | 0.82 | — | — | |
| SCHEMBL4812707 | 0.82 | — | — | |
| SCHEMBL20581882 | 0.82 | — | — | |
| SCHEMBL2987189 | 0.81 | TSHR (0.34) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL28384882 | 0.80 | — | — | |
| SCHEMBL4009243 | 0.80 | — | — | |
| SCHEMBL14991062 | 0.79 | CA1 (0.39) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL33485 | 0.79 | FAAH (0.40) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL24414491 | 0.78 | FAAH (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL24414473 | 0.78 | FAAH (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12060454-B2 | Process for the continuous production of polyoxyalkylene polyols | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-08-13 | — | — | US | disclosed |
| US-20230086177-A1 | PROCESS FOR PREPARING POLYETHER CARBONATE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2023-03-23 | — | — | US | disclosed |
| CN-115190893-A | Method for producing polyether carbonate polyols | 科思创德国股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-114729114-A | Method for producing polyether carbonate polyols | 科思创知识产权两合公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220204691-A1 | PROCESS FOR THE CONTINUOUS PRODUCTION OF POLYOXYALKYLENE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-30 | — | — | US | disclosed |
| CN-113950501-A | Method for continuously producing polyoxyalkylene polyol | 科思创知识产权两合公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-109071795-B | Method for producing polyoxyalkylene polyol | 科思创德国股份有限公司 | 2021-08-31 | — | — | CN | disclosed |
| CN-109312065-B | Method for producing polyether carbonate polyols | 科思创德国股份有限公司 | 2021-08-27 | — | — | CN | disclosed |
| US-10961346-B2 | Method for the preparation of polyoxyalkylene polyols | COVESTRO DEUTSCHLAND AG (DE) | 2021-03-30 | — | — | US | disclosed |
| US-10836858-B2 | Method for producing polyether carbonate polyols | COVESTRO DEUTSCHLAND AG (DE) | 2020-11-17 | — | — | US | disclosed |
| US-20160264727-A1 | METHOD FOR PRODUCING POLYETHER CARBONATE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2016-09-15 | — | — | US | disclosed |
| US-20160130407-A1 | POLYETHERCARBONATE-POLYOXYMETHYLENE BLOCK COPOLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2016-05-12 | — | — | US | disclosed |
| US-20150368396-A1 | FUNCTIONALIZED POLYOXYMETHYLENE BLOCK COPOLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2015-12-24 | — | — | US | disclosed |
| US-7453007-B2 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | BADGER LICENSING, LLC (US) | 2008-11-18 | — | — | US | disclosed |
| US-20050234258-A1 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | BADGER LICENSING, LLC | 2005-10-20 | — | — | US | disclosed |
| US-6930195-B2 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-08-16 | — | — | US | disclosed |
| US-20050080287-A1 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | BADGER LICENSING, LLC | 2005-04-14 | — | — | US | disclosed |
| EP-1497253-A1 | PROCESS FOR THE PRODUCTION OF UNSYMMETRIC AND/OR SYMMETRIC DIALKYL CARBONATES AND DIOLS | ExxonMobil Chemical Patents Inc. (US) | 2005-01-19 | — | — | EP | disclosed |
| WO-2003089400-A1 | PROCESS FOR THE PRODUCTION OF UNSYMMETRIC AND/OR SYMMETRIC DIALKYL CARBONATES AND DIOLS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-10-30 | — | — | WO | disclosed |
| US-6620959-B1 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | EXXONMOBIL CHEMICAL PATENTS INC. | 2003-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080287-A1 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | ACMSD, ADH1C, MSMO1 | TSHR 4352/4885CHRM2 1574/4885CHRM4 1904/4885 |
| US-20050234258-A1 | Process for the production of unsymmetric and/or symmetric dialkyl carbonates and diols | ACMSD, ADH1C, MSMO1 | TSHR 4352/4885CHRM2 1574/4885CHRM4 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.